Results 111 to 120 of about 18,162 (243)

The effect of switching protease inhibitors to raltegravir on endothelial function, in HIV-infected patients [PDF]

open access: hybrid, 2018
Maaike Krikke   +8 more
openalex   +1 more source

Long-term efficacy and safety of raltegravir in the management of HIV infection

open access: yesInfection and Drug Resistance, 2014
Michelle D Liedtke, C Ryan Tomlin, Staci M Lockhart, Misty M Miller, R Chris Rathbun Department of Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA Abstract: Raltegravir is ...
Liedtke MD   +4 more
doaj  

The efficacy and safety of a therapy regimen including raltegravir and a fixed dose combination of lamivudine and abacavir in previously rifabutin-treated patients with tuberculosis and HIV infection

open access: yesТерапевтический архив, 2014
AIM. To evaluate the efficiency and safety of using raltegravir (RAL) twice daily in conjunction with a once-daily fixed dose combination of abacavir (ABC)/lamivudine (3TC) in patients with HIV infection and active tuberculosis who have not previously ...
A V Kravchenko   +7 more
doaj  

Likelihood reweighting methods to reduce potential bias in noninferiority trials which rely on historical data to make inference

open access: yes, 2013
It is generally believed that bias is minimized in well-controlled randomized clinical trials. However, bias can arise in active controlled noninferiority trials because the inference relies on a previously estimated effect size obtained from a ...
Chu, Jianxiong   +3 more
core   +1 more source

Tratamiento anti-retroviral conteniendo raltegravir en mujeres gestantes con infección por VIH: Revisión sistemática [PDF]

open access: diamond, 2016
Lisset García‐Fernández   +3 more
openalex   +1 more source

Rapid Reduction in HIV Viral Load in Late Pregnancy with Raltegravir [PDF]

open access: gold, 2013
Agnes Cha   +3 more
openalex   +1 more source

Per què els tractaments antiretrovirals en pacients seropositius no permeten guarir la infecció definitivament? [PDF]

open access: yes, 2010
L'estudi demostra la presència de mínimes quantitats de virus que segueixen infectant noves cèl·lules en pacients seropositius malgrat els medicaments.
Buzón, María José
core   +1 more source

Nevirapine–Raltegravir Combination, An Nrti and Pi/R Sparing Regimen, as Maintenance Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients [PDF]

open access: bronze, 2013
Véronique Reliquet   +9 more
openalex   +1 more source

Haemodialysis reduces raltegravir plasma concentrations [PDF]

open access: hybrid, 2010
Sophie Bernard   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy